new BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 3 hits Enz. Inhib. hit(s) with Target = 'Sodium channel protein type 5 subunit alpha' and Ligand = 'BDBM50024132'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Sodium channel protein type 5 subunit alpha


(Homo sapiens (Human))
BDBM50024132
PNG
(CHEMBL3325530 | US9630929, Example 47)
Show SMILES Fc1ccc(cc1)C1CCNCC1(F)COc1cc(F)c(cc1F)S(=O)(=O)Nc1ncns1
Show InChI InChI=1/C20H18F4N4O3S2/c21-13-3-1-12(2-4-13)14-5-6-25-9-20(14,24)10-31-17-7-16(23)18(8-15(17)22)33(29,30)28-19-26-11-27-32-19/h1-4,7-8,11,14,25H,5-6,9-10H2,(H,26,27,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a>1.00E+4n/an/an/an/an/an/a



Xenon Pharmaceuticals Inc.

Curated by ChEMBL


Assay Description
Inhibition of human Nav1.5 expressed in HEK cells assessed as reduction in sodium current at -60 mV holding potential by PatchXpress platform based w...


Bioorg Med Chem Lett 24: 4397-401 (2014)


Article DOI: 10.1016/j.bmcl.2014.08.017
BindingDB Entry DOI: 10.7270/Q2FF3TX9
More data for this
Ligand-Target Pair
Sodium channel protein type 5 subunit alpha


(Homo sapiens (Human))
BDBM50024132
PNG
(CHEMBL3325530 | US9630929, Example 47)
Show SMILES Fc1ccc(cc1)C1CCNCC1(F)COc1cc(F)c(cc1F)S(=O)(=O)Nc1ncns1
Show InChI InChI=1/C20H18F4N4O3S2/c21-13-3-1-12(2-4-13)14-5-6-25-9-20(14,24)10-31-17-7-16(23)18(8-15(17)22)33(29,30)28-19-26-11-27-32-19/h1-4,7-8,11,14,25H,5-6,9-10H2,(H,26,27,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



XENON PHARMACEUTICALS INC.

US Patent




US Patent US9630929 (2017)


BindingDB Entry DOI: 10.7270/Q2F47R7X
More data for this
Ligand-Target Pair
Sodium channel protein type 5 subunit alpha


(Homo sapiens (Human))
BDBM50024132
PNG
(CHEMBL3325530 | US9630929, Example 47)
Show SMILES Fc1ccc(cc1)C1CCNCC1(F)COc1cc(F)c(cc1F)S(=O)(=O)Nc1ncns1
Show InChI InChI=1/C20H18F4N4O3S2/c21-13-3-1-12(2-4-13)14-5-6-25-9-20(14,24)10-31-17-7-16(23)18(8-15(17)22)33(29,30)28-19-26-11-27-32-19/h1-4,7-8,11,14,25H,5-6,9-10H2,(H,26,27,28)
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
US Patent
n/an/a>1.00E+4n/an/an/an/an/an/a



XENON PHARMACEUTICALS INC.

US Patent




US Patent US9630929 (2017)


BindingDB Entry DOI: 10.7270/Q2F47R7X
More data for this
Ligand-Target Pair